Skip to main content
Premium Trial:

Request an Annual Quote

Meridian Biosciences SARS-CoV-2 Molecular Test May Fail With Omicron Variant, FDA Says

NEW YORK – The US Food and Drug Administration released a notice on Thursday that Meridian Biosciences' Revogene SARS-CoV-2 test is unlikely to be able to detect the Omicron variant.

As a result, the test may return false negative SARS-CoV-2 results for patients with the variant.

According to the agency, the test is expected to fail to detect the variant because of a nine-nucleotide deletion in the N-gene. The genetic target of the test covers this portion of the N gene, the FDA said, which will likely result in false negative results.

The FDA noted that the deletion is specific to Omicron, so the test's performance isn't affected by other SARS-CoV-2 variants. It added that Meridian Biosciences hasn't distributed the test in the US and doesn't intend to distribute it until the issue is resolved.

The FDA's notice about Meridian was added to a more comprehensive list of tests that could be impacted by Omicron released earlier this week. The list of 27 assays from 23 developers includes tests from Thermo Fisher Scientific, Tempus Labs, Applied DNA Sciences, and the Cleveland Clinic.

Meridian's Revogene test received Emergency Use Authorization from the FDA in November, after the firm withdrew its application in February following questions from the agency and resubmitted the test in June.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.